Drugs / CYC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02727387 | Jun 2009 → Apr 2022 | Ewing sarcoma | Italian Sarcoma Group | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CYC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02727387 ↗ |
| Route | Oral | “Ciclofosfamide (oral therapy” NCT02727387 ↗ |